NCT/Study#

NCT03400332 /

CA027-002

A Phase 1/2a Study of BMS-986253 in Combination with Nivolumab in Advanced Cancers

A Phase 1/2a Study of BMS-986253 in Combination with Nivolumab in Advanced Cancers

DISEASE GROUP:
Phase 1
current phase:
Phase I/II
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information: